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  The Howard Hughes Medical Institute 
(HHMI) recently announced a policy on 
Public Access to Publications for its inves-
tigators and Janelia Farm Research Cam-
pus scientists (http://www.hhmi.org/
about/research/policies.html#papp). 
This policy requires our scientists to 
publish in only those journals that make 
original research articles and supp-
lementary materials freely accessible 
through a public database within six 
months of publication. 
  The policy seeks to balance the goal 
of public access and the equally impor-
tant value of scholarly freedom  —  the 
goal of our scientists to allow their grad-
uate students and postdoctoral fellows 
to publish their work in the journal 
of their choice. To bring more jour-
nals into compliance with our policy, 
we have concluded agreements with 
Elsevier and Cell Press, as well as other 
publishers, including the American So-
ciety of Hematology. Such conversations 
will continue with both for-profi  t and 
non-profi  t publishers. 
  Rossner and Mellman (  1  ) have crit-
icized HHMI for not using its infl  uence 
to coerce Elsevier into making their 
content public after a short delay with-
out compensation. It should be noted 
that the $1,000 we are paying for each 
Cell Press article and $1,500 for other 
Elsevier publications is not profi  t to the 
publisher, but a reimbursement for their 
lost revenue in providing accelerated 
free access and their time and eff  ort 
in uploading HHMI manuscripts to 
PubMed Central. Furthermore, HHMI 
already makes payments at a similar 
level to a wide array of non-profi  t and 
for-profi  t publishers for immediate or 
accelerated access to publications, as does 
the Wellcome Trust. 
  Scholarly publishing is in fl  ux, not 
simply in the biological sciences. Virtu-
ally all publishers, ranging from scientifi  c 
societies and non-profi  t organizations to 
major corporate entities, are  reconsidering 
their policies and business models. Now 
that the lid to the open-access publica-
tion box has been opened, there  ’  s 
no closing it again. We applaud The 
Rockefeller University Press and other 
non-profi  t publishers for taking an early 
lead in providing rapid free access to 
the scientifi  c literature. 
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  It seems clear from the HHMI response 
that they missed the point of our Edi-
torial. They note that they are provid-
ing public access to HHMI-funded 
research with their outlay of cash to 
publishers (both commercial and non-
commercial). This fact was not in 
dispute. 
  They do not, however, address the ef-
fect of their actions on the public access 
movement  —  that is, the eff  ort to get pub-
lishers (especially commercial publishers, 
who have refused to release the bulk of 
their content to the public) to provide 
public access to their holdings after a short 
delay. If the Rockefeller University Press 
does not need reimbursement to provide 
free access after 6 months, neither should 
other publishers. Elsevier already makes 
vast sums of money publishing publicly 
funded research, and they should feel an 
obligation to give something back to the 
public. Paying publishers to provide spotty 
access to just a few of the papers they 
publish (e.g., those authored by HHMI 
investigators) does not address the issue of 
public access to   all   of the scientifi  c litera-
ture. HHMI had an opportunity to exert 
some pressure on publishers to achieve 
that goal, and they chose not to do so. Al-
though they claim they were trying to 
fi  nd a balance between public access and 
“scholarly freedom,” they did not suc-
ceed. Instead, the public access movement 
has suff  ered because HHMI gave in to the 
selfi  sh desire of some of their investigators 
to continue publishing in   Cell  . This serves 
neither the public, nor science.   
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